ShereneSMinMD

PubMed

• 12 citations
  Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy.
  Ronald D'Amico, Santiago Cenoz Gomis, Riya Moodley, Rodica Van Solingen-Ristea, Bryan Baugh, Erika Van Landuyt, Veerle Van Eygen, Sherene Min, Amy Cutrell, Caroline Fo...> ;HIV Medicine. 2023 Feb 1
• Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups.
  M Keith Rawlings, Emilio Letang, Romina Quercia, Richard Grove, Ralph DeMasi, Sherene Min, Vani Vannappagari, Andrew Zolopa, Jean van Wyk, Kimberly Smith> ;Open Forum Infectious Diseases. 2022 Aug 1
• 4 citations
  Lack of pharmacokinetic interaction between the HIV-1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women.
  Teodora Pene Dumitrescu, Thomas J Greene, Samit R Joshi, Jianfeng Xu, Mark Johnson, Fiona Halliday, Laurie Butcher, Eric Zimmerman, Lindsey Webster, Theresa T. Pham, M...> ;British Journal of Clinical Pharmacology. 2021 Sep 21
• 8 citations
  A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participa...
  Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, Joyce Zhan, Mark Johnson, Laurie Butcher, Eric Zimmerman, Lindsey Webster, Antonia M Davidson, Max Lataillade, She...> ;Antimicrobial Agents and Chemotherapy. 2021 May 18
• 9 citations
  Phase I Evaluation of Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Dolutegravir in Healthy Adults.
  Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, Thomas J Greene, Mark Johnson, Laurie Butcher, Eric Zimmerman, Lindsey Webster, Theresa T. Pham, Max Lataillade, S...> ;British Journal of Clinical Pharmacology. 2021 Feb 3
• 18 citations
  Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next-generation HIV-1 maturation inhibitor.
  Samit R Joshi, Disala Fernando, Stephanie Igwe, Litza McKenzie, Anu Shilpa Krishnatry, Fiona Halliday, Joyce Zhan, Thomas J Greene, Jianfeng Xu, Geraldine Ferron-Brady...> ;Pharmacology Research & Perspectives. 2020 Dec 1
• 25 citations
  Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HI...
  Javier Morales-Ramirez, Johannes R. Bogner, Jean-Michel Molina, Johan Lombaard, Ira B. Dicker, David A. Stock, Michelle DeGrosky, Margaret Gartland, Teodora Pene Dumit...> ;Plos One. 2018 Oct 23
• 49 citations
  Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.
  Jianping Zhang, Siobhan Hayes, Brian M. Sadler, Ilisse Minto, Julie Brandt, Steve Piscitelli, Sherene Min, Ivy Song> ;British Journal of Clinical Pharmacology. 2015 Sep 1
• 251 citations
  Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
  Antonella Castagna, Franco Maggiolo, Giovanni Penco, David Wright, Anthony Mills, Robert M. Grossberg, Jean-Michel Molina, Julie Chas, J. Durant, Santiago Moreno, Manu...> ;The Journal of Infectious Diseases. 2014 Aug 1
• 375 citations
  Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label ...
  Bonaventura Clotet, Judith Feinberg, Jan van Lunzen, Marie Aude Khuong-Josses, Andrea Antinori, Irina Dumitru, Vadim Pokrovskiy, Jan Fehr, Roberto Ortiz, Michael S. Sa...> ;Lancet. 2014 Jun 28
• 101 citations
  ING116070: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in Cerebrospinal Fluid in HIV-1–Infected, Antiretroviral Therapy–Naive Subjects
  Scott Letendre, Anthony Mills, Karen T. Tashima, Deborah A. Thomas, Sherene S. Min, Shuguang Chen, Ivy Song, Stephen C. Piscitelli> ;Clinical Infectious Diseases. 2014 Jun 18
• 86 citations
  Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.
  William Spreen, Sherene Min, Susan L. Ford, S. Chen, Yu Lou, M. Bomar, M H St Clair, Steve Piscitelli, T. Fujiwara> ;HIV Clinical Trials. 2013 Sep 1
• 93 citations
  Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor, Dolutegravir, in Humans
  Stephen Castellino, Lee Moss, David S. Wagner, Julie Borland, Ivy Song, Shuguang Chen, Yu Lou, Sherene S. Min, Igor Goljer, Amanda G. Culp, Stephen C. Piscitelli, Paul...> ;Antimicrobial Agents and Chemotherapy. 2013 Aug 1
• 237 citations
  Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study
  Joseph J. Eron, Bonaventura Clotet, J. Durant, Christine Katlama, Princy Kumar, Adriano Lazzarin, Isabelle Poizot-Martin, Gary Richmond, Vincent Soriano, Mounir Ait-Kh...> ;The Journal of Infectious Diseases. 2013 Mar 1
• 227 citations
  Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, r...
  Jan van Lunzen, Franco Maggiolo, Jose R. Arribas, A Rakhmanova, Patrick Yeni, Benjamin Young, Jürgen K. Rockstroh, Steve Almond, Ivy Song, Sherene Min> ;The Lancet. Infectious Diseases. 2012 Feb 1
• 159 citations
  Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.
  Sherene Min, Louis Sloan, Edwin DeJesus, Trevor Hawkins, Lewis McCurdy, Ivy Song, Richard Stroder, Shuguang Chen, Mark R. Underwood, Tamio Fujiwara, Stephen C. Piscite...> ;AIDS. 2011 Sep 10
• 51 citations
  Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next‐generation HIV integrase inhibitor, S/GSK1349572
  Ivy Song, Julie Borland, Shuguang Chen, Yu Lou, Amanda Peppercorn, Toshihiro Wajima, Sherene Min, Stephen C. Piscitelli> ;British Journal of Clinical Pharmacology. 2011 Jul 1
• 58 citations
  Effects of Etravirine Alone and with Ritonavir-Boosted Protease Inhibitors on the Pharmacokinetics of Dolutegravir
  Ivy Song, Julie Borland, Sherene Min, Yu Lou, Shuguang Chen, Parul Patel, Toshihiro Wajima, Stephen C. Piscitelli> ;Antimicrobial Agents and Chemotherapy. 2011 Jul 1
• 62 citations
  Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers
  Parul Patel, Ivy Song, Julie Borland, Apurva Patel, Yu Lou, Shuguang Chen, Toshihiro Wajima, Amanda Peppercorn, Sherene S. Min, Stephen C. Piscitelli> ;The Journal of Antimicrobial Chemotherapy. 2011 Apr 14
• 48 citations
  The effect of lopinavir/ritonavir and darunavir/ritonavir on the HIV integrase inhibitor S/GSK1349572 in healthy participants
  Ivy Song, Sherene S. Min, Julie Borland, Yu Lou, Shuguang Chen, Parul Patel, Toru Ishibashi, Stephen C. Piscitelli> ;Journal of Clinical Pharmacology. 2011 Feb 1
• 25 citations
  Lack of interaction between the HIV integrase inhibitor S/GSK1349572 and tenofovir in healthy subjects.
  Ivy Song, Sherene S. Min, Julie Borland, Yu Lou, Shuguang Chen, Toru Ishibashi, Toshihiro Wajima, Stephen C. Piscitelli> ;Journal of Acquired Immune Deficiency Syndromes. 2010 Nov 1
• 15 citations
  Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.
  Sherene S. Min, J. Rick Turner, Adel Nada, Tara L. Dimino, Ivo Hynie, Robert Kleiman, Peter R. Kowey, Mitchell W. Krucoff, Jay W. Mason, Alex Phipps, Christopher Newto...> ;American Heart Journal. 2010 May 1
• 182 citations
  Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers.
  Sherene Min, Ivy Song, Julie Borland, Shuguang Chen, Yu Lou, Tamio Fujiwara, Stephen C. Piscitelli> ;Antimicrobial Agents and Chemotherapy. 2010 Jan 1
• 45 citations
  Steady-State Pharmacokinetics of Abacavir in Plasma and Intracellular Carbovir Triphosphate following Administration of Abacavir at 600 Milligrams Once Daily and 300 M...
  Graeme Moyle, Marta Boffito, Carl Fletcher, Chris Higgs, Phillip Hay, Ivy Song, Yu Lou, Geoffrey J. Yuen, Sherene S. Min, Elena M. Guerini> ;Antimicrobial Agents and Chemotherapy. 2009 Apr 1
• 22 citations
  Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.
  Hiba L. Tappouni, John C Rublein, Brian J. Donovan, Stephanie B. Hollowell, Hsiao Chuan Tien, Sherene S. Min, Dickens Theodore, Naser L. Rezk, Philip C. Smith, Melanie...> ;American Journal of Health-System Pharmacy. 2008 Mar 1
• Join now to see all